Despite risk of breast cancer, few men undergo genetic tests, study finds

June 1, 2018, University of California, Los Angeles
Credit: CC0 Public Domain

Cancer is one of the leading causes of death among Americans. At least 10 percent of cancers are caused by inherited mutations in genes such as BRCA1 and BRCA2. Parents with the cancer gene mutation have a 50 percent chance of passing it on to a son or daughter. It's well-known that women with BRCA are at a very high risk for breast and ovarian cancer. Less known is the fact that men with these mutations also are at risk of breast cancer and other cancers.

A study published in April in JAMA Oncology finds that few men are screened for these genetic mutations—and the researchers strongly suggest that they be screened.

"If a male has a BRCA mutation, his risk of increases a hundredfold," said Dr. Christopher Childers, a resident physician in the department of surgery at the David Geffen School of Medicine at UCLA and the paper's senior author. "BRCA mutations also put men at higher risk for often aggressive prostate cancers that occur at younger ages. These mutations have also been associated with other cancers, such as pancreatic and melanoma.

This may be the first national study analyzing the rates of genetic cancer testing for both men and women, Childers said.

Analyzing data from the 2015 National Health Interview Survey, the researchers found that nearly 2.5 million people underwent cancer genetic testing. This includes testing for genes related to breast/ovarian cancer such as BRCA, but also those related to risk for colorectal and other cancers. Of the 2.5 million people, nearly three times as many women received testing compared with men (73 percent vs. 27 percent).

Credit: University of California, Los Angeles

The researchers also found that the disparity in testing was specific to breast/ovarian cancer. Men underwent testing for /ovarian cancer genes at one-tenth the rate of women. There was no gender disparity for colorectal or other cancer testing.

Fewer Latinos, the uninsured, non-citizens, and residents with less education received genetic testing compared with the rest of the population.

The next step is to determine why so few men get tested and find ways to increase those rates, said lead author Kimberly Childers, a genetics counselor and regional manager of the Providence Health & Services Southern California's Clinical Genetics and Genomics program.

"Previous studies have shown that men don't necessarily understand the importance of a mutation—that it is more of a 'feminine' issue—but this couldn't be further from the truth," she said. "We hope this study will spur broad national educational efforts."

The authors noted that the survey was based on self-reported data from patients, which can sometimes be unreliable; and limited details regarding the reasons why patients underwent testing.

Explore further: Breast cancer genes a real risk for men, too

More information: Kimberly K. Childers et al. National Distribution of Cancer Genetic Testing in the United States, JAMA Oncology (2018). DOI: 10.1001/jamaoncol.2018.0340

Related Stories

Breast cancer genes a real risk for men, too

April 26, 2018
(HealthDay)—Few American men are screened for gene mutations that can greatly increase their risk of breast and other types of cancers, a new study reveals.

Gender disparity observed in cancer genetic testing in the U.S.

May 3, 2018
(HealthDay)—Specific demographic groups have lower cancer genetic testing, including unaffected men compared with unaffected women, according to a research letter published online April 26 in JAMA Oncology.

Beyond BRCA: Links between breast, second primary cancer and inherited mutations

May 31, 2018
Rates of inherited mutations in genes other than BRCA1/2 are twice as high in breast cancer patients who have had a second primary cancer—including, in some cases, different types of breast cancer—compared to patients ...

Busting myths surrounding cancer and genetic testing

April 13, 2018
(HealthDay)—While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests.

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

Males with BRCA mutations have increased risk of certain cancers

April 17, 2018
(HealthDay)—Males with BRCA mutations have increased incidence of malignant disease, specifically prostate, melanoma, pancreas, and breast cancers, according to a research letter published online April 12 in JAMA Oncology.

Recommended for you

Scientists discover new method of diagnosing cancer with malaria protein

August 17, 2018
In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilising a particular malaria protein that sticks to cancer ...

Researchers find pathways that uncover insight into development of lung cancer

August 17, 2018
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants. One of these genetic components, ...

Developing an on-off switch for breast cancer treatment

August 17, 2018
T-cells play an important role in the body's immune system, and one of their tasks is to find and destroy infection. However, T-cells struggle to identify solid, cancerous tumors in the body. A current cancer therapy is using ...

Pregnant? Eating broccoli sprouts may reduce child's chances of breast cancer later in life

August 16, 2018
Researchers at the University of Alabama at Birmingham have found that a plant-based diet is more effective in preventing breast cancer later in life for the child if the mother consumed broccoli while pregnant. The 2018 ...

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

August 15, 2018
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.